Cryogenex Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth 55.54%
- Profit Growth -69.92%
- Ebitda 1060.39%
- Net Worth 0.12%
- Total Assets 9.81%
About Cryogenex Diagnostics
Cryogenex Diagnostics Private Limited (CDPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 September 2010 and has a history of 14 years and four months. Its registered office is in Jammu, Jammu & Kashmir, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manoranjan Pradhan and Parbati Palata serve as directors at the Company.
Company Details
-
Location
Jammu, Jammu & Kashmir, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100JK2010PTC003210
-
Company No.
003210
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Sep 2010
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Jammu
Industry
Who are the key members and board of directors at Cryogenex Diagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoranjan Pradhan
|
Director | 28-Mar-2019 | Current |
|
Parbati Palata
|
Director | 10-Sep-2010 | Current |
Financial Performance of Cryogenex Diagnostics.
Cryogenex Diagnostics Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 55.54% increase. The company also saw a substantial fall in profitability, with a 69.92% decrease in profit. The company's net worth moved up by a moderate rise of 0.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cryogenex Diagnostics?
In 2017, Cryogenex Diagnostics had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Mediclean Tech Private LimitedManoranjan Pradhan is a mutual person
-
Cryogenex Medical Science & Research LlpManoranjan Pradhan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cryogenex Diagnostics?
Unlock and access historical data on people associated with Cryogenex Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cryogenex Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cryogenex Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
